Nkarta to Participate in Evercore Healthcare Conference

Core Insights - Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing engineered natural killer (NK) cell therapies for autoimmune diseases [1][3] - The company will participate in the Evercore 8th Annual Healthcare Conference on December 4, 2025, featuring a fireside chat at 10:50 a.m. ET [2] - Nkarta aims to create allogeneic, off-the-shelf NK cell therapies by utilizing its cell expansion and cryopreservation platform combined with proprietary cell engineering technologies [3] Company Overview - Nkarta is advancing a pipeline of NK cell therapies designed for deep therapeutic activity and broad outpatient access [3] - The company emphasizes the importance of its proprietary technologies in enhancing the effectiveness of its therapies [3] - For further information, Nkarta maintains a dedicated section on its website for investors [2][3]